KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exact Sciences (EXAS) Operating Income (2016 - 2025)

Exact Sciences has reported Operating Income over the past 16 years, most recently at -$82.6 million for Q4 2025.

  • Quarterly Operating Income rose 90.58% to -$82.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$206.3 million through Dec 2025, up 80.33% year-over-year, with the annual reading at -$206.3 million for FY2025, 80.33% up from the prior year.
  • Operating Income was -$82.6 million for Q4 2025 at Exact Sciences, down from -$25.5 million in the prior quarter.
  • Over five years, Operating Income peaked at $6.8 million in Q3 2023 and troughed at -$876.4 million in Q4 2024.
  • The 5-year median for Operating Income is -$101.4 million (2024), against an average of -$146.0 million.
  • Year-over-year, Operating Income skyrocketed 104.96% in 2023 and then plummeted 1191.77% in 2024.
  • A 5-year view of Operating Income shows it stood at -$221.4 million in 2021, then soared by 46.32% to -$118.9 million in 2022, then surged by 42.93% to -$67.8 million in 2023, then plummeted by 1191.77% to -$876.4 million in 2024, then surged by 90.58% to -$82.6 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Operating Income are -$82.6 million (Q4 2025), -$25.5 million (Q3 2025), and -$2.1 million (Q2 2025).